Oncolytics Biotech, Inc. (ONCY)
0.79
-0.03
(-3.66%)
USD |
NASDAQ |
May 21, 16:00
0.7901
0.00 (0.00%)
After-Hours: 19:59
Oncolytics Biotech Research and Development Expense (TTM) : 10.77M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 5.703B |
| Karyopharm Therapeutics, Inc. | 124.57M |
| Replimune Group, Inc. | 222.70M |
| Sensei Biotherapeutics, Inc. | 13.28M |
| Tango Therapeutics, Inc. | 127.14M |